Baxter International Inc.

Baxter Healthcare Sa

Baxalta Gmbh

Paul Jeffrey Sanders

Ton That Hai

Sujatha Karoor

Leo Martis

Cong Jiang

Paul J Soltys

Salim Mujais

Rahul Tandon

Stavroula Morti

Tuan Bui

David R Lamb

Larry Richard Brown

Michael Dockal

Luis Lu

Mari Katada

Brian Donovan

Mark Nordhaus

Ozlem Yardimci

Kent Lane Lurvey

Arounaguiry Ambroise

Vadim V Krongauz

Guohan Yang

Bennett Melnick

Krishnakumarsinh Hitendrasinh Parmar

Jie Li

Catherine Quinn

Cliff Holmes

Jerome Schafer

Susanne Till

Sabine Knappe

Ben Melnick

Alexander Wesley Scott

Alyssa Sanders

Adam Christopher Mercer

John Barry

Ben Ko

Stephanie Klunk

Fritz Scheiflinger

Prasad Dande

Fritz Schleiflinger

Delivery devices, delivery systems, and related methods, for precise administration of hemostatic compositions are disclosed, which may include a trigger mechanism, a pusher, a valve, and a cannula. The pusher is configured to engage with the trigger mechanism, retain a first syringe, a least by coupling with a plunger of the first syringe. The valve is fluidly coupled to the first syringe. The valve is further configured to engage with a second syringe, in fluid communication with both the valve and the first syringe. The cannula extends distally from and is fluidly coupled to the valve. Activation of the trigger mechanism causes the pusher and the plunger of the first syringe to translate in a distal direction, to expel a composition out of the first syringe, through the valve, through the cannula, and out of a distal end of the cannula.

Dual check valve one handed applicator

Polymeric compositions, methods, and delivery devices for inhibiting bleeding are disclosed. The method includes applying a dried material topically to a wound site, where the material may include a cross-linked biologically compatible polymer which forms a hydrogel when exposed to blood and where the material may not include an active agent such as thrombin. A spring-loaded delivery device as described herein may be used to apply the dried material.

Polymeric compositions, delivery devices, and methods

Spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients as well as methods of manufacturing the thrombin materials and methods of treating bleeding wounds are disclosed. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.

Spray-dried thrombin and methods of using and making spray-dried thrombin

Methods and devices for providing dialysis treatment are provided. The device comprises a cartridge for providing regenerative dialysis, the cartridge comprising: a body having an inlet and an outlet and defining an interior, the interior including at least a layer comprising urease, a layer comprising zirconium oxide, a layer comprising zirconium phosphate, and a layer comprising carbon, wherein at least two of the layers are blended together to provide a gradient of the two materials.

System, method, and composition for removing uremic toxins in dialysis processes

A method for immobilizing dyes and antimicrobial agents on a polymeric cover or housing for a medical device is disclosed and described. The surface may be that of a catheter, a connector, a drug vial spike, a bag spike, a prosthetic device, an endoscope, a surface of an infusion pump, a key pad, a touch screen or a handle. The surfaces may also be one or more of those associated with a infusion of a medicament or dialysis treatment, such as peritoneal dialysis or hemodialysis, where it is important that the working surface for the dialysis fluid be sterile. These surfaces include connectors for peritoneal dialysis sets or for hemodialysis sets, bag spikes, dialysis catheters, and so forth. A method for determining whether a surface has been sterilized, and a dye useful in so indicating, is also disclosed.

Antimicrobial housing and cover for a medical device

Therapeutic compositions capable of removing excess nitric oxide are provided. The therapeutic compositions include nitronyl nitroxide monoradicals, B12 derivatives, flavonoid derivatives, the like and combinations thereof. The therapeutic compositions can be utilized in a number of suitable applications, such as to prevent or treat intradialytic hypotension during dialysis.

Nitric oxide scavengers

Method and composition for removing uremic toxins in dialysis processes

The present invention relates to polymeric derivatives, which can be conjugated to an amino-containing drug to improve its in vivo properties. The polymeric derivative can subsequently be released to yield the drug in its native form. Methods of preparing and using these polymeric derivatives and drug conjugates are described.

Polymeric benzyl carbonate-derivatives

Methods and devices for providing dialysis treatment are provided. The device includes a resin bed including zirconium phosphate, zirconium oxide, and urease.

Growing community of inventors

Greendale, WI, United States of America

Paul Jeffrey Sanders